A61K 31/559
Having heterocyclic rings containing hetero atoms other than oxygen
Official title: having heterocyclic rings containing hetero atoms other than oxygen
A61K31/559 (Having heterocyclic rings containing hetero atoms other than oxygen) appears on 92 US grants and 118 published applications in this corpus.
Search patents in A61K- Granted patents
- 92
- Published applications
- 118
- Assignees
- 36
- Inventors
- 135
- Latest grant
- 7 Jul 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1994 | 1 | 0 |
| 1995 | 0 | 0 |
| 1996 | 2 | 0 |
| 1997 | 5 | 0 |
| 1998 | 3 | 0 |
| 1999 | 3 | 0 |
| 2000 | 5 | 0 |
| 2001 | 4 | 2 |
| 2002 | 5 | 4 |
| 2003 | 4 | 8 |
| 2004 | 4 | 5 |
| 2005 | 2 | 6 |
| 2006 | 0 | 0 |
| 2007 | 0 | 2 |
| 2008 | 1 | 4 |
| 2009 | 1 | 2 |
| 2010 | 3 | 3 |
| 2011 | 5 | 7 |
| 2012 | 2 | 5 |
| 2013 | 3 | 2 |
| 2014 | 4 | 10 |
| 2015 | 1 | 5 |
| 2016 | 6 | 11 |
| 2017 | 8 | 11 |
| 2018 | 6 | 4 |
| 2019 | 1 | 4 |
| 2020 | 5 | 6 |
| 2021 | 3 | 6 |
| 2022 | 0 | 4 |
| 2023 | 1 | 1 |
| 2024 | 2 | 4 |
| 2025 | 0 | 1 |
| 2026 | 2 | 1 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Biodegradable drug-polymer conjugate7 Jul 2026US 12,673,064 B2Polyactiva Pty Ltd
- Methods for treating diseases associated with ciliopathies27 Jan 2026US 12,533,362 B2Alexion Pharmaceuticals, Inc.
- Intraocular implant with high loading of a prostamide11 Jun 2024US 12,004,995 B2Allergan, Inc.
- Composition and method of using eicosanoyl-5-hydroxytryptamide for treating neurodegenerative disorders13 Feb 2024US 11,896,600 B2Vidya Herbs, Inc.
- Anti-SEZ6L2 antibodies and antibody drug conjugates25 Apr 2023US 11,634,486 B2Bluefin BioMedicine, Inc.
- Ophthalmic solutions for canine, feline & equine glaucoma and oht1 Oct 2026US 2026/0294797 A1
- Intraocular implant with high loading of a prostamide2 Jan 2025US 2025/0000695 A1Allergan, Inc.
- Prostamide-containing intraocular implant31 Oct 2024US 2024/0358714 A1Allergan, Inc.
- Pharmaceutical composition for improving cardiac function20 Jun 2024US 2024/0197753 A1Cuorips Inc.
- Prostamide-containing intraocular implant9 May 2024US 2024/0148750 A1Allergan, Inc.
Most cited
By later US patents
- Cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl derivatives as therapeutic agents217US 5,688,819 AAllergan, Inc. · 1997
- Non-acidic cyclopentane heptanoic acid,2-cycloalkyl or arylalkyl derivatives as therapeutic agents177US 6,403,649 B1Allergan Sales, Inc. · 2002
- Non-acidic cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl derivatives as therapeutic agents111US 5,352,708 AAllergan, Inc. · 1994
- Non-acidic cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl derivatives as therapeutic agents75US 5,607,978 AAllergan, Inc. · 1997
- Cyclopentane heptan(ene)oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents49US 6,037,364 AAllergan Sales, Inc. · 2000